Please use this identifier to cite or link to this item:
|Title:||A case report of congenital glycogen storage liver cirrhosis treated with bone marrow derived stem cells||Authors:||Wehbe, Terek W
Abi Chahine, Nassim H
Annous, Abdul-Rahman A
Ferri, Mohammad A
Boulous, Robert C
El-Mestrah, Majid F
|Affiliations:||Faculty of Health Sciences||Keywords:||Mononuclear stem cells
Bone marrow cells
|Issue Date:||2017||Publisher:||National Library of Medicine||Part of:||Stem Cell Investigation||Volume:||4||Issue:||9||Abstract:||
Liver cirrhosis represents a state of end-stage failure that is usually fatal. The condition results in liver dysfunction, recurrent ascites, encephalopathy, renal failure, splenomegaly, bleeding, and a poor quality of life in general. With the current severe shortage of donated organs, the only available treatment in the developing countries remains palliative care. We report a case of congenital metabolic liver cirrhosis due to glycogen storage disease diagnosed at age eight. The patient, a male, received bone marrow derived mononuclear cells (BMMC) at age 16 and again at age 17 with significant improvement of his biochemical liver function tests, ascites build-up, asthenia, splenomegaly and quality of life. Furthermore, liver biopsies showed clear reduction of the inflammation and fibrosis from Ishak score dropped from 3 to 1 paralleling the symptomatic improvement of the patient.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/5891||ISSN:||2306-9759||DOI:||10.21037/sci.2017.07.04||Open URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Department of Medical Laboratory Sciences|
Show full item record
checked on Aug 14, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.